Discover
APYX
Apyx Medical Corporation
2.59
2 x 1.88
2 x 3.11
bid
ask
+
0.23
9.75%
2 @ 04:00 PM
2.65 +0.06 (2.32%)
| Ytd | -26.00% | |
| 1y | -13.38% |
2.38
day range
2.62
2.36
52 week range
4.86
| Open | 2.38 | Prev Close | 2.36 | Low | 2.38 | High | 2.62 | Mkt Cap | 109.10M |
| Vol | 107.41K | Avg Vol | 127.72K | EPS | -0.20 | P/E | N/A | Forward P/E | -3.39 |
| Beta | 1.21 | Short Ratio | 5.49 | Inst. Own | 40.43% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 3.10 | 200-d Avg | 3.69 | 1yr Est | 2.83 |
| Income Statement | |||
| Total Revenue | 13.88M | ||
| Revenues (USD) | 13.88M | ||
| Cost of Revenue | 5.01M | ||
| Gross Profit | 8.87M | ||
| Operating Expenses | 10.68M | ||
| Research and Development Expense | 793.00K | ||
| Selling, General and Administrative Expense | 9.88M | ||
| Operating Income | -1.81M | ||
| Interest Expense | 1.39M | ||
| Income Tax Expense | 124.00K | ||
| Net Income | -3.24M | ||
| Net Income Common Stock | -3.24M | ||
| Net Income Common Stock (USD) | -3.24M | ||
| Consolidated Income | -3.07M | ||
| Net Income to Non-Controlling Interests | 171.00K | ||
| Earnings per Basic Share | -0.07 | ||
| Earnings per Basic Share (USD) | -0.07 | ||
| Earnings per Diluted Share | -0.07 | ||
| Earning Before Interest & Taxes (EBIT) | -1.72M | ||
| Earning Before Interest & Taxes (USD) | -1.72M | ||
| Weighted Average Shares | 41.87M | ||
| Balance Sheet | |||
| Cash and Equivalents | 27.62M | ||
| Cash and Equivalents (USD) | 27.62M | ||
| Trade and Non-Trade Receivables | 13.61M | ||
| Current Assets | 53.16M | ||
| Property, Plant & Equipment Net | 6.14M | ||
| Total Assets | 61.07M | ||
| Debt Current | 472.00K | ||
| Total Debt | 39.63M | ||
| Current Liabilities | 9.35M | ||
| Debt Non-Current | 39.16M | ||
| Total Liabilities | 49.98M | ||
| Accumulated Retained Earnings (Deficit) | -94.47M | ||
| Shareholders Equity | 10.66M | ||
| Shareholders Equity (USD) | 10.66M | ||
| Assets Non-Current | 7.92M | ||
| Total Debt (USD) | 39.63M | ||
| Deferred Revenue | 1.13M | ||
| Inventory | 10.75M | ||
| Liabilities Non-Current | 40.63M | ||
| Trade and Non-Trade Payables | 2.19M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 211.00K | ||
| Net Cash Flow from Financing | -5.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.52M | ||
| Capital Expenditure | -66.00K | ||
| Issuance (Repayment) of Debt Securities | -5.00K | ||
| Net Cash Flow from Investing | -66.00K | ||
| Net Cash Flow from Operations | -3.49M | ||
| Effect of Exchange Rate Changes on Cash | 41.00K | ||
| Share Based Compensation | 1.07M | ||